214 related articles for article (PubMed ID: 21375480)
21. New views on antidepressant action.
Baudry A; Mouillet-Richard S; Launay JM; Kellermann O
Curr Opin Neurobiol; 2011 Dec; 21(6):858-65. PubMed ID: 21530233
[TBL] [Abstract][Full Text] [Related]
22. Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.
Wilkinson ST; Holtzheimer PE; Gao S; Kirwin DS; Price RB
Biol Psychiatry; 2019 Mar; 85(6):454-465. PubMed ID: 30528745
[TBL] [Abstract][Full Text] [Related]
23. Animal models of depression and neuroplasticity: assessing drug action in relation to behavior and neurogenesis.
Xu Y; Barish PA; Pan J; Ogle WO; O'Donnell JM
Methods Mol Biol; 2012; 829():103-24. PubMed ID: 22231809
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoids in the treatment of mood disorders: evidence from animal models.
Bambico FR; Duranti A; Tontini A; Tarzia G; Gobbi G
Curr Pharm Des; 2009; 15(14):1623-46. PubMed ID: 19442178
[TBL] [Abstract][Full Text] [Related]
25. New understanding of mechanisms of action of bipolar medications.
Sanacora G
J Clin Psychiatry; 2008; 69 Suppl 5():22-7. PubMed ID: 19265637
[TBL] [Abstract][Full Text] [Related]
26. [Neuroplasticity and depression].
Czéh B; Simon M
Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
[TBL] [Abstract][Full Text] [Related]
27. Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression.
Wang J; Jing L; Toledo-Salas JC; Xu L
Neurosci Bull; 2015 Feb; 31(1):75-86. PubMed ID: 25488282
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide signalling and antidepressant action revisited.
Joca SRL; Sartim AG; Roncalho AL; Diniz CFA; Wegener G
Cell Tissue Res; 2019 Jul; 377(1):45-58. PubMed ID: 30649612
[TBL] [Abstract][Full Text] [Related]
29. Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects.
Rantamäki T; Kohtala S
Pharmacol Rev; 2020 Apr; 72(2):439-465. PubMed ID: 32139613
[TBL] [Abstract][Full Text] [Related]
30. New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.
Huang YJ; Lane HY; Lin CH
Neural Plast; 2017; 2017():4605971. PubMed ID: 28491480
[TBL] [Abstract][Full Text] [Related]
31. The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.
Ferrari F; Villa RF
Mol Neurobiol; 2017 Sep; 54(7):4847-4865. PubMed ID: 27510505
[TBL] [Abstract][Full Text] [Related]
32. Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity.
Pilar-Cúellar F; Vidal R; Díaz A; Castro E; dos Anjos S; Vargas V; Romero B; Valdizán EM
Curr Pharm Des; 2014; 20(23):3776-94. PubMed ID: 24180397
[TBL] [Abstract][Full Text] [Related]
33. From restoration of neuroplasticity to the treatment of depression: clinical experience.
Costa e Silva JA
Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S511-21. PubMed ID: 15550350
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.
Tartt AN; Mariani MB; Hen R; Mann JJ; Boldrini M
Mol Psychiatry; 2022 Jun; 27(6):2689-2699. PubMed ID: 35354926
[TBL] [Abstract][Full Text] [Related]
35. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.
Sheng J; Liu S; Wang Y; Cui R; Zhang X
Neural Plast; 2017; 2017():9724371. PubMed ID: 28706741
[TBL] [Abstract][Full Text] [Related]
36. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.
Samuels BA; Mendez-David I; Faye C; David SA; Pierz KA; Gardier AM; Hen R; David DJ
Neuroscientist; 2016 Feb; 22(1):26-45. PubMed ID: 25488850
[TBL] [Abstract][Full Text] [Related]
37. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.
Köhler S; Cierpinsky K; Kronenberg G; Adli M
J Psychopharmacol; 2016 Jan; 30(1):13-22. PubMed ID: 26464458
[TBL] [Abstract][Full Text] [Related]
38. Does neurotropin-3 have a therapeutic implication in major depression?
Pae CU; Marks DM; Han C; Patkar AA; Steffens D
Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant-elicited changes in gene expression: remodeling of neuronal circuits as a new hypothesis for drug efficacy.
Yamada M; Yamada M; Higuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):999-1009. PubMed ID: 15975701
[TBL] [Abstract][Full Text] [Related]
40. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
